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Abstract 
Introduction: Osteoarthritis (OA) is a highly heterogenous disease influenced by different 
molecular, anatomic and physiologic imbalances. Some of the bottlenecks for enhanced 
diagnosis and therapeutic assessment are the lack of validated biomarkers and early 
diagnosis tools. In this narrative review, we analyze the potential of Raman spectroscopy 
(RS) as a label-free optical tool for the characterization of articular joint tissues and its 
application as a diagnosis tool for OA. 
Areas covered: Raman spectra produce a unique “molecular fingerprint” providing 
rotational and vibrational molecular information, allowing the identification and follow-up of 
molecular changes associated with OA pathological mechanisms. Focusing on multiple 
joint tissues (cartilage, synovium, bone, tendons, ligaments and meniscus) and their 
contribution in disease incidence and progression, this review highlights the current 
knowledge on the application of RS in the characterization of organic and inorganic 
molecules present at these tissues and alterations that occur in the onset of OA.  
Expert Opinion: Vibrational spectroscopy techniques, such as RS, are low cost, rapid and 
minimally invasive approaches that offer high specificity in the assessment of the 
molecular composition of complex tissues. Combined with multivariate statistical methods, 
RS offers great potential for optical biomarkers discovery or disease diagnosis applications, 
and we hereby discuss clinical translational progresses on the field. 
 
1. Introduction 
Osteoarthritis (OA) is a chronic and multifactorial disease affecting 50% of the population 
over 65 years, being one of the main causes of disability in the aged population [1]. OA is 
a disorder involving the movable joints characterized by cell stress and extracellular matrix 
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degradation, initiated by micro/macro-injuries that activate maladaptive repair responses. 
The disease initially manifests as a molecular derangement followed by anatomic and/or 
physiologic imbalances that culminate in illness [2]. Being highly heterogenous, OA can be 
classified in different phenotypes with people presenting very different clinical 
manifestations and outcomes. Moreover, the presence of multiple joints and tissues in the 
musculoskeletal system complicate disease incidence and progression. Nowadays, there 
is no cure and even though drugs available alleviate pain and clinical therapies help 
halting or minimizing joint damage progression, there are still unmet needs to deliver more 
efficient treatments, such as validated biomarkers or improved early diagnosis techniques 
[3,4]. 
One of the main limitations for OA early diagnosis lies on the onset of the disease itself, as 
in its initial phases it is asymptomatic and when patients attend physicians, they present 
charateristics above the subclinical threshold [2]. After patient history review and physical 
examination [5], OA clinical diagnosis is confirmed by joint radiography, the gold standard 
technique, or magnetic resonance imaging (MRI). Severity of OA can then be classified 
according to Kellgren-Lawrence (K-L) grading system, between 0 (healthy) and IV (severe 
OA) grades [6–8]. This indirect classification method identifies changes in the joint bone 
tissue, osteophytosis and joint space narrowing, but is insufficient to detect small changes 
in cartilage [9]. On the other hand, MRI allows the analysis of surface and depth lesions, 
as well as the visualization of pre-radiographic alterations in multiple tissues or intra-
articular bodies, for which a MRI-based OA definition is available [10,11]. However, 
application of a strong electromagnetic field invalidates this method for patients with metal 
implants or other medical devices. In addition, MRI routine use for OA diagnosis would be 
unrealistic for public health systems due to high costs [12,13]. Other method for articular 
damage assessment is arthroscopy, which detects chondropathies in early OA, but image 
analysis is subjective and leads to a certain degree of intervariability [14]. Moreover, 
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cartilage degradation evaluation can be complemented with histomorphometric 
evaluations, such as the Kraus’ modified Mankin Score or the histopathology OARSI 
(Osteoarthritis Research Society International) system [15]. 
Given the limitations of conventional techniques for OA diagnosis and its increasing 
prevalence it is paramount to develop non- or minimally-invasive techniques, capable of 
detecting damage or changes at the molecular level. Biochemical biomarkers have 
emerged as promising tools with enhanced sensitivity and reliability regarding the 
imaging techniques available. These could facilitate early diagnosis of joint destruction, 
disease prognosis and monitoring of progression through biochemical tests [4]. Even 
though significant advances have been made due to proteomic tools using blood serum, 
synovial fluid or cell secretome, up to now, only candidate biomarkers have been 
described related to pathological mechanisms of OA [3,16,17]. 
Raman spectroscopy (RS) is an emerging biomedical technology in the study of diseased 
tissues and could offer significant improvements for the early diagnosis for a variety of 
musculoskeletal diseases, including OA, and the definition of optical biomarkers [18,19]. 
RS is based on the inelastic photonic dispersion that occurs when a monochromatic light 
beam hits a molecule, providing rotational or vibrational modes information. A given 
Raman spectrum represents specific peaks or bands at a certain frequency or wavelength, 
constituting a well-defined “molecular fingerprint” of the tissue analyzed (Figure 1) [20]. 
Raw data will then be typically preprocessed in order to overcome baseline interference 
and may also involve peak normalization [21,22]. Thereafter, data can be classified 
according to unsupervised or supervised statistical methods, allowing sample classification 
(biomarkers) or diagnostic analysis, where the latest involves the use of additional 
information obtained from gold standards, such as histopathology or radiography scores. 
Importance should also be given to the impact of inter- and intra-variability when using the 
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aforementioned scores [23]. Moreover cross-validation against biochemical tools is 
frequently included [24]. 
Due to alternative processing pathways, data is not always suitable for direct comparison. 
Nonetheless, mean Raman spectra and the corresponding algorithm-based extracted data 
can be interpreted and discussed in the context of Raman shifts corresponding to 
biological and/or biochemical assignments in cartilage or surrounding tissues. Protocol 
standardization is thus fundamental in order to overcome limitations of RS for cartilage 
tissue analysis, such as high fluorescence or weak signal strength inherent to most 
biological samples that influence spectral quality and detection accuracy [25].  
In addition, RS presents other advantages, such as time and cost of analysis efficience 
[24], as it can be performed directly on a very small volume of sample and it does not 
suffer from interference from water molecules. Other vibrational spectroscopic techniques, 
i.e., Fourier transform infrared (FTIR), and near infrared (NIR) spectroscopies can also be 
combined with Raman, enabling assessment of quantitative and qualitative features of 
articular cartilage, which have been reviewed elsewhere [26]. 
The main goal of this narrative review was to analyse available data on RS for the 
characterization of cartilage and other articular joint tissues that present alterations during 
OA progression, shedding light on its potential for OA diagnosis and optical biomarkers. 
2. Raman Spectroscopy for OA diagnosis 
2.1. Redefining articular cartilage characterization  
The analysis of articular cartilage by RS can be found in the literature from 2006 onwards, 
including studies using different human joint tissues and/or animal model validation (Table 
1). Eventhough RS allows a non-invasive analysis of cartilage, most references describe 
studies with sample pre-treatment, such as paraffin, formalin, poly(methyl methacrylate) 
(PMMA) or cryomatrix, from which signal contribution can be easily identified in the spectra, 
although caution should be taken when comparing to fresh tissue [18,19,27–30]. In 
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addition, as lasers can be coupled to microscopes, it is possible not only to study 
alterations in superficial cartilage but also in transversal sections.  
Articular cartilage is a connective tissue formed by chondrocytes [31], embedded in an 
extracellular matrix (ECM), composed by collagens, mainly type-II (Col-II) [32], 
proteoglycans (PGs), lipids and other minority non collagenous proteins. PGs are 
composed of protein units of aggrecan linked to hyaluronan fibers, constituing a protein 
core that connects one or more glycosaminoglycan (GAGs) chains. Due to cartilage 
composition, Raman spectra are complex, being predominantly dominated by the 
presence of bands associated with the aforementioned matrix proteins. 
Dehring et al. [33], early described articular cartilage molecular composition using RS, in a 
mice model. A molecular fingerprint of articular cartilage is depicted in Figure 2A and the 
assignments corresponding to the different bands related to cartilage components, type 
and bond mode are detailed in Table 2. Briefly, the main bands that have been associated 
with proteins are as follows: the doublet 856-880 cm-1, related to the distribution of 
proline/hydroxyproline (Pro-Hyp), the amino acids band, at 1004 cm-1 [34], related to 
phenylalanine [19,27], commonly used as a normalization band [28], and the doublet at 
1245-1270 cm-1 (amide III), related to the secondary structure of proteins and their relative 
distribution [35]. In addition to the bands associated with collagen, cartilage spectra 
reveals a peak at 1063 cm-1, corresponding to sulfated GAGs, with a predominant 
contribution of chondroitin sulfate (CS) [18,27,28,34,36] and other specific bands related to 
GAGs, such as the pyranose ring, at 1039-52 cm-1 [34]. When mineralized tissue is 
present, interferences at 1063 cm-1 have been reported, due to an overlapping carbonate 
band, at 1070 cm-1. Alternatively, 1375 cm-1 has been suggested to study PG alterations 
[36]. Moreover, in overdamaged tissues where the subchondral bone is exposed, an 
additional band can be identified at 958 cm-1, attributed to phosphate minerals [27]. More 
recently, Mansfield and Winlove [30] studied lipids distribution, identifying two related 
    
 
 
6 Information Classification: General 
regions: a band at 1441 cm-1 and 2845-2930 cm-1 displacements. 
The first study using RS for detecting joint damage in human cartilage has established 
ratios for tissue degradation, such as cartilage-to-bone ratio (1063/958), phosphate to 
collagen ratio (958/920) (a measure of mineral/organic ratio), and carbonate to phosphate 
ratio (1070/958) (indicating the degree of carbonate substitution in hydroxyapatite crystals), 
corresponding to molecular events described during OA progression [27]. These events 
were associated with collagen degradation and disorganization, already observed in early 
stages, and PGs content abrupt decrease in more advanced stages of the disease [37]. 
These can also be related to mineralization processes, as nucleation and crystal 
deposition of basic calcium phosphate (BCP) around collagen fibers are favoured with 
GAGs decrease [38]. In addition, recent studies have described an indirect lipid index (IL, 
1450/1668) which increases with OA radiological progression (K-L grade) [39]. Some of 
these molecular changes can be observed in Figure 2B that depicts RS spectra from 
human cartilage tissue derived from patients with different K-L grades. Given the pivotal 
role of cartilage mechanical properties, Lim et al., used a porcine model to study healthy 
cartilage subjected to different loads. The authors demonstrated that GAGs-related bands 
decreased in impact groups, indicative of PG loss, which was also confirmed by 
histomorphological analysis. Moreover, variations in the Pro-Hyp ratio and the shift of 
amide III band to a doublet of peaks were both related to changes in collagen structure. 
Variables such as cartilage thickness affected RS results, as observed by the presence of 
a phosphate band, at 957 cm-1, in impact groups-only that correlated with a decrease in 
cartilage thickness and thus greater laser penetration into deeper layers [34]. 
Bergholt and coworkers developed a RS-image analysis method based on mapping 
intensities of specific signals across the surface of transversal sections of bovine cartilage. 
Their goal was to study depth-dependent relative composition and collagen fibers’ 
orientation within cartilage zonal arquitecture [29]. By complementing RS with multivariate 
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analysis, they established and validated six clearly defined and differentiated zones, in 
contrast with the commonly accepted four histological areas (superficial, intermediate, 
deep zone and subchondral bone). Later, a biochemical quantification of these zonal 
gradients supported the reliability of this technique to detect depth-dependent 
arrangements [40]. Recently, the authors offered a comprehensive review of RS for 
cartilage extracellular matrix (ECM) and other tissues, discussing further challenges in 
biomedical applications [41]. Raman confocal microscopy studies were also carried out at 
single-cell level using isolated chondrocytes of patients with different International 
Cartilage Repair Society (ICRS) grades that have shown a concomitant decrease in 
protein and nucleic acid levels and an increase of lipid deposits with disease progression 
[42]. 
2.2. Synovium 
The synovial membrane is a connective tissue that lines the inner side of the diarthrodial 
joints, tendon sheaths and joint pockets [43]. It produces the synovial fluid (SF), composed 
of an ultrafiltrate of blood supplemented with additives, produced by synoviocytes. Its 
function is to nourish cartilage and lubricate joints for which lubricin, a glycocomposite 
binded to hyaluronan (HA), plays a major role [44–46]. During OA, synovial fluid proteins 
become progressively denatured [47]. Plasma infiltration induces a decrease in HA 
concentration and molecular weight, caused by abnormal metabolic processes [48]. These 
changes result in the loss of SF lubricating properties and viscosity [44,49]. In addition, 
there is an increase in inorganic crystals and cytokines that can also cause synovitis or 
inflammation of the synovial membrane [50]. 
SF aspirates are currently been studied using proteomics and mass spectrometry 
approaches, defining different profiles of proteins, metabolites or other substances, for the 
diagnosis of rheumatic diseases, including OA [51–54]. Even though it is not possible to 
extract information from precise proteins using Raman spectra, joint damage could be 
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predicted by analyzing variations of HA in deposited droplets of SF. Dehring et al., 
designed a SERS method, based on the analysis of artificial SF, for HA quantification, 
validated under detection limits appropriate to its’ concentration range in OA synovium 
[48]. As a decrease in HA is associated with a loss of SF viscoelastic properties, in the 
onset of OA, it could constitute a potential biomarker for the early stages of the disease. 
Other authors have examined human SF derived from knee OA patients, using combined 
SERS and resonant Raman spectra, being able to discriminate low- from high-grade 
groups with a classification accuracy of 100% [55]. 
Another study with SF from healthy and radiographic joint damage patients (K-L: 0-I vs II-
IV) reported a significant decrease in proteins with alpha-helix structure, entailing 
alterations in the chemical environment of the protein backbone, in OA patients [56]. This 
could be related to other observations on the macromolecular level, such as the release of 
Col-II fragments from adjacent tissues [57]. Furthermore, an association between SF 
droplets’ morphology and OA damage has been suggested. In one hand, joint damage 
was weakly correlated with the presence of ferm-shaped crystals in SF droplets’ core, 
whilst a moderate correlation was found with the presence of radial cracks at the droplets’ 
edge. When spectra was obtained from different regions in the droplet, significant results 
were found amongst different ratios, related to protein bonds (1080/1001 cm-1, 1080/1125 
cm-1 and 1655/1448 cm-1) and their relative secondary structure (1235/1260 cm-1 and 
1670/1655 cm-1) [57]. RS has also been used to detect crystalline deposits in SF, from 
urate and calcium - basic calcium phosphate (BCP) or calcium pyrophosphate dihydrate 
(CPPD), with potential for diagnosing other rheumatic diseases, such as gout and 
pseudogout [58–61]. Some of these compounds have also been suggested as indicators 
of joint space reduction that occurs during OA progression [62]. 
2.3. Bone  
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Bones constitute the basic anatomical structure in the human body around which other 
musculoskeletal tissues are arranged. Bone is formed by organic and inorganic 
components, varying in proportion depending on the type of bone, age, diet and disease 
processes [63–65]. In contrast to cartilage, the most abundant collagen is from type-I (Col-
I) and bone mineral is constituted of a carbonated form of a nanoscrystalline 
nonstoichiometric apatite [66,67]. RS has been extensively applied for bone properties 
assessment and characterization, summarized elsewhere [68,69]. The most characteristic 
assigned bands for bone, by RS are thus, those related to the mineral components, 
specifically hydroxyapatite phosphate (v1 PO4
3-, v2 PO4
3- and v3 PO4
3-) and B-type 
carbonate (v1 CO3
2-) (Table 2). Nonetheless, even though bone mineral apatite consists 
mainly of B-type carbonate, it has been reported the presence of A-type carbonate (1114 
cm-1) in older bones [69]. Additionally, nonspecific signals related to the organic fraction of 
the tissue (amide III doublet and amide I), can be found [27,70]. Other parameters have 
also been covered, such as mineral to matrix ratio, mineral maturity/crystallinity, relative 
carbonate content or relative tissue water content/porosity [71]. 
During OA progression, alterations in the subchondral bone occur due to bone overgrowth, 
a process known as osteophytosis [6]. Also, OA patients suffer from a decrease in bone 
quality and microhardness making them more susceptible to bone injuries [72]. Several RS 
studies reported differences in bone tissues from healthy and OA patients [70,73]. A 
concomitant decrease in hydroxyapatite to collagen ratios (960/1244 cm-1 and 960/1268 
cm-1) and an increase in carbonate to phosphate ratio (1071/960 cm-1) would most likely 
be related to compensatory mechanisms in response to a mineralization deficit. In addition, 
an increase in collagen secondary structure disarrangement (1268/1244 cm-1) indicated a 
disorganization of collagen in the bone matrix. These alterations were found in the 
subchondral bone derived from OA femoral heads. However, when analyzing cancellous 
bone, which lays directly under the subchondral bone, significant differences were not 
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found [70]. In more recent studies, two-dimensional Raman maps were used to calculate 
the degree of bone mineralization (DBM) in cancellous and subchondral bone from femoral 
heads, by integrating hydroxyapatite’ signal relative intensity to that of collagen [63]. The 
results were consistent with a decrease in the subchondral bone mineralization, although it 
is not yet fully supported that this parameter can provide an accurate diagnosis of OA by 
itself. Kerns et al., performed a similar study in tibial plateau, reporting bone matrix 
chemistry changes for OA tissues [74]. 
2.4. Tendons and ligaments  
Tendons and ligaments are a type of fibrous connective tissue present in the joints. 
Tendons and ligaments are mainly composed of Col-I, so their spectra are dominated by 
bands of this component (Table 2). Other non-collagenous proteins, lipids and 
proteoglycans can be found in a very low percentage, and thus have a limited overall 
contribution, with the additional limitation that their corresponding bands overlap with those 
of collagen [66,75]. 
Frushour and Koening [76], took the first step in studying the composition of tendons by 
RS. The authors identified bands at 1248 and 1271 cm-1, related to amide III vibrations. 
The most relevant signals found in tendons, were those of amide I, at 1665 cm-1, the 
CH2/CH3 deformation, at 1457-64 cm
-1, the amide III envelope, at 1220-1280 cm-1, and the 
C-C bound (Pro-Hyp), at 820-80 cm-1 [77,78]. These assignments were used as references 
for identifying variations in collagen backbone or fibers orientation, under tension 
conditions, that support RS application for determining tension in ligaments and tendons 
[79,80]. Later, this technology was suggested to monitor mechanical properties of 
ligaments, such as tensile stress, during knee surgery, promoting better ligament fixation, 
by setting a proper tension in a repaired or grafted tissue, contributing to a normal 
kinematics of the knee [81]. Moreover, analysis of supraspinatus tendon enthesis spectra 
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led to the identification of a mineralization gradient associated to mineral crystallinity 
across the tendon-bone insertion site [82–84]. 
During OA, both tendons and ligaments become progressively weaker and inflammatory 
processes can be triggered. Ligament degradation or displacement is usually related with 
disease progression [85–87] and ligament instability may produce changes in tension 
distributions that can accelerate the disease [88]. So far, only one study has demonstrated 
an increase in ligament stiffness in OA patients [89], although no references were found 
for the application of RS in the evaluation of tendons and ligaments during OA. 
2.5. Meniscus  
The meniscus is a structure present at the knee joint and its main role is load distribution. 
It is a fibrocartilaginous tissue with Col-I and -II and GAGs as main components [90]. 
When meniscus’ function is altered due to its deterioration, imbalance in load distribution 
causes damage to both cartilage and the subchondral bone, inducing OA [91]. During 
disease progression, meniscal tissue undergoes variations in its mechanical properties 
[92,93]. Moreover, at the biochemical level, collagen fibers become disorganized and 
tissue calcifications appear [94,95].  
Levillain et al. [91], used RS to study changes in the meniscus of rabbits in an early OA 
model. The main Raman signals identified in the meniscus were those related with 
proteins, such as proline (857 cm-1), hydroxyproline (877 cm-1), phenylalanine (1004 cm-1), 
amide III (1220-1280 cm-1), C-H organic bond (1447-1452 cm-1) and amide I (1666 cm-1). 
Disarrangement of collagen networks, as well as an increase in GAGs, in response to 
degradation, were observed in histological stainings, although these were not evident in 
Raman spectra, suggesting there could be limitations in assessing early OA stages. 
Moreover, mineralization assessment of the meniscus was previously performed in 
advanced OA tissue, identifying hydroxyapatite (960 cm-1) and CPPD deposits (1049 cm-1) 
[96]. 
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3. RS for OA candidate biomarkers 
According to this literature review, Figure 3 represents a selection of bands and ratios that 
could constitute a panel of biomarkers for OA, considering changes in the different tissues 
present in the joint. Briefly, in cartilage, proline to hydroxyproline (856/880 cm-1) and 
random coil to α-helix secondary structure (1245/1270 cm-1) ratios could be involved with 
changes in collagen synthesis or randomness, respectively, and bands at 1063, 1040, and 
1375 cm-1 could be related to proteoglycans relative content. Other ratios could be 
considered to assess cartilage quality and tissue mineralization processes, such as 
cartilage to bone (1063/958 cm-1), bone to collagen (960/920 cm-1), and carbonate to 
phosphate (1070/958 cm-1) ratios [27]. Some of these ratios have been lately validated 
against K-L grade, Mankin Score and biochemical assays [97]. Concomitantly, changes in 
bone during OA could be detected by hydroxyapatite to collagen (960/1245 cm-1 and 
960/1270 cm-1), carbonate to phosphate (1070/960 cm-1) and collagen randomness 
(1270/1245 cm-1) ratios. Regarding SF, a candidate for liquid biopsy, proposed bands are 
the following: 899, 940, 1050, 1130 cm-1, as well as 1410 cm-1, to identify HA, previously 
suggested as an OA biomarker [48]. In addition, protein (1080/1001 cm-1, 1080/1125 cm-1 
and 1655/1448 cm-1) and collagen structure ratios (1235/1260 cm-1 and 1670/1655 cm-1) 
also offer potential. Finally, in the meniscus, the main biomarkers that could indicate tissue 
damage would be those related to calcium deposits (960 cm-1 and 1049 cm-1). 
4. Conclusions 
Raman spectroscopy is a promising technique for the detection and assessment of 
musculoskeletal joint tissues molecular composition with high clinical significance for the 
diagnosis of osteoarthritis. In this narrative review, we have highlighted the contribution of 
RS in detecting and characterizing alterations in organic and inorganic molecules, present 
in the multiple joint tissues, which occur in the onset of OA. Future steps include in one 
hand, overcoming technical limitations and on the other, defining and validating a panel of 
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optical biomarkers based on variations on the molecular fingerprint of healthy cartilage 
and/or complemented with those from surrounding tissues, which are also affected during 
this multifactorial and heterogenous disease. 
5. Expert Opinion 
Osteoarthritis imposes great challenges for the treating physician. Despite significant 
socioeconomic burden, existing resources are still insufficient for an early diagnosis. The 
heterogeneity of the disease and a considerable variability in the trajectory of its prognosis, 
with some individuals experiencing progression whilst others remain stable for several 
years, has led to the consideration of OA as a syndrome comprised of multiple and distinct 
phenotypes rather than a single disease. Even though efforts have been made to identify 
clinically relevant OA phenotypes, there is still a lack of standardization [98,99]. Due to its 
high molecular specificity and the possibility of a fast and economic monitoring, RS could 
help to better define patients’ subgroups.  
RS is currently being tested in clinical settings to measure bone transcutaneously and has 
been assessed in an early stage clinical trial for osteoporosis, OA and osteogenesis 
imperfecta (ClinicalTrials.gov Identifier: NCT02814591). Most Raman instruments are 
compatible with fiberoptic probes, which could be used in different approaches, through 
arthroscopes during arthroscopic surgery or in needle arthroscopes available in 
ambulatory offices [100]. For instance, fiber-optic RS for arthroscopy has been tested in a 
proof of principle study for cartilage-bone analysis in human individuals, in exposed tissues 
[27], supporting its suitability for medical environment. More recently, a similar approach, 
has been developed using infrared fibre probe coupled to an arthroscope [101]. These 
studies are thus paving the way for the clinical translation of fiberoptics that could 
differentiate heterogeneties in cartilage, as a complementary tool to the clinic [27,41]. 
Another translational application regarding cartilage is the application of RS to detect and 
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monitor ochronotic and non-ochronotic tissues, a clinical feature of alkaptonuria rare 
disorder [102]. 
6. Five-year view 
As novel approaches towards understanding the progression of OA are being made, the 
discovery and validation of biomarkers will support better managing disease progression 
and improve prognosis. As such, RS is a powerful source for the obtainance of label-free 
optical biomarkers giving new insights in the molecular basis of OA and providing reliable 
biomolecular information for diagnosis and treatment evaluation, as it is being considered 
for other diseases [102–104]. Indeed, as explored in this review, several joint tissues have 
been independently evaluated, identifying specific signals that could constitute candidate 
biomarkers (Figure 3), yet these need further analytical validation. New paradigms can 
also have an impact on the focus given in RS applications for OA diagnosis. For example, 
according to current literature, strong evidence has demonstrated that bone changes are 
not simply a secondary sign of OA, but can be an initiating factor of degeneration of the 
joint, suggesting changes in the molecular structure of the subchondral bone may precede 
cartilaginous changes in the OA joint [105]. Some advances have already been made to 
shed light on the role of bone in OA using RS. Kerns and coworkers have shown 
preliminary results on early alterations in bone matrix changes in the subchondral bone of 
control and OA tibial plateaus [106] and another study in femoral heads revealed that OA 
subchondral bone is hypermineralised, supported by an increase in the phosphate-to-
amide I ratio and a decrease in carbonate substitution into apatite crystals [107].  
 In addition, technical limitations still need to be overcome, such as tissue 
autofluorescence, low signal intensity, or possible phototoxic effects after prolonged 
exposure to the laser. Several solutions are currently being explored that involve the use 
of low energy NIR lasers (λ=785, 830 and 1064 nm), the optimization of parameters suchs 
as laser power or exposure time that can minimize the signal-to-noise ratio, or establishing 
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standardized protocols that involve mathematical and computational modeling in spectra 
data processing and analysis [22]. Indeed, the implementation of more advanced 
multivariate or machine learning approaches is being explored under unsupervised and 
supervised algorithms. For example, k-means clustering of full cartilage spectra has been 
suggested as an exploratory technique to group similar spectra and can elucidate into 
samples that have similar or different composition [38]. Also, a recent study applied k-
means clustering of selected signals/ratios (960/1004 cm-1, 1063/1004 cm-1 and 
1245/1270 cm-1) of spectra obtained from human OA cartilage, derived from femoral 
condyle and head, which led to the definition of two clusters, corresponding to a low and a 
high severity profile, validated against K-L grade and histological Mankin Score (MS). 
Based on this, a predictive model, using receiver operating characteristic (ROC) curves, 
has been explored, setting up specific thresholds, being able to discriminate patients with 
high OA severity (K-L≥III and MS≥9) with a probability of more than 80% [108]. Finally, 
considering that OA affects different joints, most frequently knee, hip, hands and the spine, 
but also being increasingly seen in ankles and feet, it is expected that due to the flexibility 
of Raman spectroscopy technology, the number of studies will continue to increase. 
7. Article Highlights 
- Raman spectroscopy is able to successfully discriminate between healthy and 
osteoarthritic joint tissues. 
- Raman spectra provide detection and monitoring of cartilage molecular alterations at 
different stages of OA. 
- A panel of Raman signals and ratios assigned to cartilage tissue components can be 
related to specific events that occur during tissue destruction and thus are proposed as OA 
optical biomarkers. 
- RS has high potential as a rapid and economic method for OA early diagnosis. 
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